e-learning
resources
Vienna 2009
Monday, 14.09.2009
Models of chronic airways disease and therapy
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effects of lipopolysaccharide (LPS) from E. coli 0111:B4 on electrical field stimulation (EFS) response in human isolated bronchi
L. Calzetta, M. G. Matera, M. Cazzola (London, United Kingdom; Naples, Rome, Italy)
Source:
Annual Congress 2009 - Models of chronic airways disease and therapy
Session:
Models of chronic airways disease and therapy
Session type:
Thematic Poster Session
Number:
2061
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Calzetta, M. G. Matera, M. Cazzola (London, United Kingdom; Naples, Rome, Italy). Effects of lipopolysaccharide (LPS) from E. coli 0111:B4 on electrical field stimulation (EFS) response in human isolated bronchi. Eur Respir J 2009; 34: Suppl. 53, 2061
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Lipopolysaccharide (LPS) inhalation causes an increase in mucosal CD8+ve cells
Source: Eur Respir J 2001; 18: Suppl. 33, 316s
Year: 2001
Differential properties of mucosubstance produced by allergic inflammation and lipopolysaccharide (LPS) stimulation in rat nasal epithelium
Source: Eur Respir J 2002; 20: Suppl. 38, 482s
Year: 2002
Effect of lipopolysaccharide (LPS) priming on
Candida
-induced acute lung injury (ALI)
Source: Eur Respir J 2003; 22: Suppl. 45, 585s
Year: 2003
Lipopolysaccharide (LPS) inhalation causes an increase in activated neutrophils and lymphocytes
Source: Eur Respir J 2001; 18: Suppl. 33, 108s
Year: 2001
Endotoxin from
E. coli
(LPS) increases human isolated airway tone by unbalancing e- i-NANC system
Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators
Year: 2010
The failure rate of sputum induction following inhaled lipopolysaccharide (LPS) challenge in healthy subjects
Source: Annual Congress 2008 - COPD: from bench to bedside
Year: 2008
Activation of mammalian target of rapamycin (mTOR) in a murine model of lipopolysaccharide (LPS) -induced acute lung injury
Source: Annual Congress 2010 - Acute respiratory failure
Year: 2010
Intranasal administration of lipopolysaccharide (LPS) during a chronic pulmonary infection with
streptococcus pneumoniae
resulted in a synergistic effect on neutrophil influx in mice
Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections
Year: 2014
IL-6 and IL-8 production induced by Pseudomonas aeruginosa flagellin in human bronchial epithelial cells.
Source: International Congress 2017 – Infection and exacerbation science
Year: 2017
In vivo and in vitro regulation of angiopoietin expression by bacterial lipopolysaccharides (LPS)
Source: Annual Congress 2008 - Respiratory structure and function
Year: 2008
Inhaled CCR1 antagonist AZD4818 reduces leucocyte influx in the rat lipopolysaccharide (LPS) lung inflammation model
Source: Annual Congress 2009 - Preclinical models in drug development
Year: 2009
Mycoplasma pneumoniae extract induced IL-6 and TNF-α production by RAW264.7 cells
Source: Annual Congress 2009 - Inflammatory cells and cytokines
Year: 2009
Characterization of airway remodeling following lipopolysaccharide exposure
Source: Eur Respir J 2005; 26: Suppl. 49, 560s
Year: 2005
Extracellular vesicles derived from mesenchymal stem cells prevent pulmonary vascular dysfunction induced by lipopolysaccharide (LPS).
Source: International Congress 2018 – Experimental research in pulmonary hypertension
Year: 2018
The effect of heat co-treatment on acute lung injury of the rat induced by intratracheal lipopolysaccharide
Source: Eur Respir J 2002; 20: Suppl. 38, 488s
Year: 2002
Human mesenchymal stem cell microvesicles for the treatment of Escherichia coli endotoxin-induced acute lung injury
Source: International Congress 2016 – Extracellular vesicles in lung disease pathogenesis
Year: 2016
The relevance of epidemic ET-12
B. cenocepacia
lipopolysaccharide (LPS) structure and cytokine induction capacity compared to other
burkholderia cepacia
complex species
Source: Eur Respir J 2006; 28: Suppl. 50, 485s
Year: 2006
Induction of type-IIA secretory phospholipase A2 in animal models of acute lung injury
Source: Eur Respir J 2003; 21: 1040-1045
Year: 2003
Effect of CD14 blockage and Toll-like receptor 4 mutation on NF-κB translocation after intratracheal instillation of LPS in murine lungs
Source: Eur Respir J 2003; 22: Suppl. 45, 531s
Year: 2003
Pseudomonas aeruginosa flagellin modulates the immune response in ex vivo lung tissue slices
Source: International Congress 2019 – Mechanisms underlying respiratory infection
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept